TerminatedNot Applicable

Identification of Human Biomarkers Predictive of Diabetes Remission in Type 2 Diabetes Patient (BARIAKINES)

Stopped: Inclusion difficulties

France23 participantsStarted 2023-02-27

Plain-language summary

This study focuses on identifying potentially predictive human circulating adipocyte and muscle biomarkers of diabetes remission after bariatric surgery in obese type 2 diabetic (T2D) subjects.

Who can participate

Age range

18 Years – 70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Obese patients of at least grade 2 (body mass index ≥ 35 kg/m²) * Type 2 diabetics * About to undergo bariatric surgery at the Toulouse University Hospital * Affiliated or beneficiaries of a social security plan. * Having provided a free, informed and written consent, signed Exclusion Criteria: * Type 1 diabetic subjects or Maturity-Onset Diabetes of the Youth. * Pregnant and breastfeeding women. * Vulnerable persons as defined in the Public Health Code: protected adults (guardianship, curators), unable to express their consent.

What they're measuring

Correlation between plasma levels of 9 target molecules and diabetes remission

Timeframe: Immediately before the Surgery (day 0)

Correlation between plasma levels of 9 target molecules and diabetes remission

Timeframe: At 3 months post-surgery

Correlation between plasma levels of 9 target molecules and diabetes remission

Timeframe: At 12 months post-surgery

Trial details

NCT IDNCT05472883

SponsorUniversity Hospital, Toulouse

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-27

View on ClinicalTrials.gov More Type 2 Diabetes trials